Analyst Downgrades: Bank of America Corp, Valeant Pharmaceuticals Intl Inc, and Workday Inc

Analysts downwardly revised their ratings and price targets on Bank of America Corp (BAC), Valeant Pharmaceuticals Intl Inc (VRX), and Workday Inc (WDAY)

Mar 1, 2016 at 9:29 AM

Analysts are weighing in on financial giant Bank of America Corp (NYSE:BAC), drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and cloud concern Workday Inc (NYSE:WDAY). Here's a quick roundup of today's bearish brokerage notes on BAC, VRX, and WDAY.

Raymond James weighed in on a number of bank stocks, including BAC -- where the brokerage firm cut its price target to $16 from $17.50. Ahead of the bell, though, the shares are 1.3% higher, after closing at $12.52 yesterday. It's been a rough 2016 for Bank of America Corp, which has lost more than one-quarter of its value on a year-to-date basis amid sector-wide headwinds. Not surprisingly, the stock's options pits are tilted in a decidedly bearish direction. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), BAC's 10-day put/call volume ratio of 0.31 ranks in the top quartile of its annual range, indicating traders have been buying to open bearish bets over bullish at a quicker-than-usual clip of late.

In what's becoming a pattern, VRX received yet another round of bearish brokerage notes this morning. This time, RBC downgraded its rating on the stock to "sector perform" from "outperform" and slashed its price target to $85 from $194. In addition, Jefferies cut its price target to $106 from $172. On the charts, Valeant Pharmaceuticals Intl Inc has gotten buried, and yesterday it lost 18.4% to $65.80 after the company confirmed it faces "several ongoing investigations" by regulators, and received a subpoena from the Securities and Exchange Commission (SEC). Nonetheless, the stock has crept 0.4% higher ahead of the open. On the options front, short-term traders have rarely been so call-skewed toward VRX in the past year, based on its Schaeffer's put/call open interest ratio (SOIR) of 0.92 -- which sits below 95% of all other readings from the prior 12 months.

WDAY is set to pop 7.2% at the open, after the company reported higher-than-expected revenue during the fourth quarter. However, the software maker's sales guidance disappointed, prompting a raft of price-target cuts on Wall Street. No fewer than 10 analysts lowered their price targets on Workday Inc, with only Piper Jaffray breaking ranks -- raising its price target to $61 from $48. On the charts, the shares have been coming back since hitting a three-year low of $47.32 on Feb. 9, up 27.7% at $60.45. Option traders aren't buying the bounce, based on WDAY's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.39, which ranks in the bearishly skewed 70th annual percentile.

Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Follow @Schaeffers

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?